Literature DB >> 19934567

Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.

Keivan Basiri1, Masoud Etemadifar, Amir Hadi Maghzi, Neda Zarghami.   

Abstract

This study was designed to determine the frequency and clinical characteristics of myasthenia gravis (MG) in a large cohort of Persian patients with multiple sclerosis (MS) living in the province of Isfahan. We reviewed the case records of patients with definite MS (McDonald's criteria) registered in the Isfahan MS Society (IMSS) for associated MG. Of the 1,718 patients with MS in the registry, six patients were found to have both MS and MG. The prevalence after excluding one patient with insufficient data, was 291 per 100,000 (0.29%), a higher prevalence than the earlier reports. These results may support the hypothesis that MS and MG share some common immunopathogenic mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19934567     DOI: 10.4103/0028-3886.57817

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  8 in total

1.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

Review 2.  Cross-syndrome: myasthenia gravis and the demyelinating diseases of the central nervous system combination. Systematic literature review and case reports.

Authors:  Ekaterina Luzanova; Svetlana Stepanova; Nikita Nadtochiy; Elena Kryukova; Maria Karpova
Journal:  Acta Neurol Belg       Date:  2022-06-14       Impact factor: 2.396

Review 3.  Multiple Sclerosis and Autoimmunity: A Veiled Relationship.

Authors:  Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar; Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy
Journal:  Cureus       Date:  2022-04-19

4.  Myasthenia gravis development and crisis subsequent to multiple sclerosis.

Authors:  Kurosh Gharagozli; Maziar Shojaei; Ali Amini Harandi; Nayyereh Akbari; Manouchehr Ilkhani
Journal:  Case Rep Med       Date:  2011-05-18

Review 5.  A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Per S Sorensen; Gary Cutter; Stephen C Reingold; Maria Trojano
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 6.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

Review 7.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

Review 8.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.